Neuronetics, Inc.
STIM
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$1.60
FAIR PRICE
$0.80
MARGIN
$0.80
P/E Ratio
N/A
Div. Yield
N/A
ROE
-138.9%
Market Cap
$99M
Small-cap
COMING SOON
Get notified when STIM's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
Keith J. Sullivan
COUNTRY
US
HEADQUARTERS
Malvern
SECTOR
Healthcare
EXCHANGE
NASDAQ
METHODOLOGY
How we calculate STIM's fair price
Neuronetics, Inc.'s fair price of $0.80 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%). At the current market price of $1.60, STIM trades 50.0% above its calculated fair value.
DCF MODEL · 50%
Discounted cash flow analysis based on projected free cash flows, discounted at a rate reflecting STIM's risk profile.
RELATIVE · 30%
Comparing STIM's valuation multiples against Healthcare peers.
ANALYST · 20%
Aggregated analyst price targets for STIM, weighted by recency and analyst accuracy.
POWERED BY BULIOS
Get full analysis, financials, and AI insights for STIM.
Explore on BuliosFAQ
What is the fair price of STIM?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Neuronetics, Inc. is $0.80. At the current market price of $1.60, STIM trades 50.0% above its calculated fair value.
Is STIM overvalued or undervalued?+
Neuronetics, Inc. is currently overvalued based on our valuation model. The stock trades at $1.60, which is 50.0% above the fair price of $0.80.
How often is STIM's fair price updated?+
We update fair price calculations for STIM daily after market close. The current fair price of $0.80 incorporates the latest market data and sector multiples.
What factors affect STIM's fair price calculation?+
STIM's fair price of $0.80 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of -138.9%.
Is STIM a good buy right now?+
At $1.60, STIM trades 50.0% above our fair value estimate of $0.80. The stock is currently overvalued. ROE stands at -138.9% (average). Fair Price Index provides valuation data — always do your own research before investing.
Does STIM pay dividends?+
STIM does not currently pay a dividend.